Contract research in preclinical development

Discovery, lead optimization, and investigative toxicology

In mid-March every year, the world’s toxicologists meet at the Society of Toxicology’s Annual Meeting. The latest best practices, data and regulatory expectations are shared and discussed.

IPST has supported the SOT for over 25 years, and this year again, our scientists will share the latest innovations in investigative toxicology.

01 / Cardiovascular

Cardiovascular diseases

We leverage our world-class expertise on cardiovascular diseases, e.g., pulmonary arterial hypertension, myocardial infarction, hemorrhagic shock, acute kidney injury, to craft tailored protocols designed in collaboration with you.

02 / Inflammatory

Inflammatory disorders

We leverage our world-class expertise on inflammatory disorders, e.g., diabetes, obesity, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, liver fibrosis, cholestatic liver disease, to craft tailored protocols designed in collaboration with you.

03 / Respiratory

Respiratory diseases

We leverage our world-class expertise on respiratory diseases e.,g., chronic obstructive pulmonary disease, asthma, allergic rhinitis, pulmonary fibrosis, to craft tailored protocols designed in collaboration with you.

04 / Bleeding

Bleeding disorders

We leverage our world-class expertise on bleeding disorders, e.g., hemophilia, sickle cell anemia, immune thrombocytopenia, von Willebrand disease, to craft tailored protocols designed in collaboration with you.